-
DBTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Decibel Therapeutics (DBTX)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.74 mm | 40.74 mm | 40.74 mm | 40.74 mm | 40.74 mm | 40.74 mm |
Cash burn (monthly) | (no burn) | 1.40 mm | 6.35 mm | 5.50 mm | 3.42 mm | 4.07 mm |
Cash used (since last report) | n/a | 28.05 mm | 127.35 mm | 110.35 mm | 68.68 mm | 81.61 mm |
Cash remaining | n/a | 12.69 mm | -86.62 mm | -69.62 mm | -27.94 mm | -40.87 mm |
Runway (months of cash) | n/a | 9.1 | -13.6 | -12.7 | -8.2 | -10.0 |
13F holders | Current |
---|---|
Total holders | 37 |
Opened positions | 3 |
Closed positions | 6 |
Increased positions | 5 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 55.80 bn |
Total shares | 22.23 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 4.95 mm | $19.04 bn |
Third Rock Ventures III | 3.14 mm | $0.00 |
TRV GP Iii | 3.14 mm | $12.09 bn |
REGN Regeneron Pharmaceuticals | 2.10 mm | $9.75 mm |
BLK BlackRock | 1.81 mm | $6.97 bn |
GOOG Alphabet | 1.64 mm | $6.30 bn |
GV 2016 | 1.64 mm | $0.00 |
Samsara BioCapital | 801.63 k | $3.09 bn |
Vanguard | 642.33 k | $2.47 bn |
Bessemer | 494.07 k | $1.90 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Sep 23 | Anna Trask | Common Stock | Sale back to company | Dispose D | No | No | 0 | 106,864 | 0.00 | 0 |
25 Sep 23 | Anna Trask | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.4 | 137,302 | 604.13 k | 0 |
25 Sep 23 | Anna Trask | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.5 | 52,500 | 183.75 k | 0 |
25 Sep 23 | Anna Trask | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.12 | 45,000 | 140.40 k | 0 |
25 Sep 23 | Mclaughlin Kevin F | Common Stock | Sale back to company | Dispose D | No | No | 0 | 5,000 | 0.00 | 0 |
25 Sep 23 | Mclaughlin Kevin F | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.78 | 5,000 | 23.90 k | 0 |
25 Sep 23 | Mclaughlin Kevin F | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.88 | 20,000 | 57.60 k | 0 |
25 Sep 23 | Matthew C Kapusta | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,000 | 0.00 | 0 |
25 Sep 23 | Matthew C Kapusta | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.34 | 10,000 | 33.40 k | 0 |
25 Sep 23 | Alison Cecily Finger | Common Stock | Sale back to company | Dispose D | No | No | 0 | 5,000 | 0.00 | 0 |